Market Tracker

07/28 5:16pm ET

Endocyte Inc (NASDAQ:ECYT)

3.18
Delayed Data
As of 3:59pm ET
 -0.02 / -0.63%
Today’s Change
2.65
Today|||52-Week Range
5.87
-20.70%
Year-to-Date

Today’s Trading

Previous close3.20
Today’s open3.19
Day’s range3.16 - 3.23
Volume79,263
Average volume (3 months)156,172
Market cap$134.9M
Dividend yield--
Data as of 3:59pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)-12.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.05+1.65%
EIGREiger BioPharmaceuti...+0.24+1.21%
AQXPAquinox Pharmaceutic...+0.09+1.09%
CLCDCoLucid Pharmaceutic...+0.02+0.22%
Data as of 3:59pm ET, 07/28/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts